Skip to main content Published: Jul 29, 2022 OTTAWA, Ontario–(BUSINESS WIRE)– Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal
Read More